{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:46Z","timestamp":1786118866785,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/psy.0b013e31816aa0cc","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T21:09:31Z","timestamp":1206997771000},"page":"505-511","source":"Crossref","is-referenced-by-count":118,"title":["Prevalence and Comorbidity of Psychiatric Diagnoses Based on Reference Standard in an HIV+ Patient Population"],"prefix":"10.1097","volume":"70","author":[{"given":"Bradley N.","family":"Gaynes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Wells","family":"Pence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210213","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1176\/appi.ajp.157.2.248","article-title":"Impact of psychiatric conditions on health-related quality of life in persons with HIV infection.","volume":"157","author":"Sherbourne","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R2-18-20210213","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.285.11.1466","article-title":"Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study.","volume":"285","author":"Ickovics","year":"2001","journal-title":"JAMA"},{"key":"R3-18-20210213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0006-3223(03)00323-8","article-title":"HIV disease progression: depression, stress, and possible mechanisms.","volume":"54","author":"Leserman","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R4-18-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/QAI.0b013e31802c2f51","article-title":"Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.","volume":"44","author":"Pence","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-18-20210213","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.","volume":"13","author":"Gordillo","year":"1999","journal-title":"AIDS"},{"key":"R6-18-20210213","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/infdis\/168.5.1157","article-title":"Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine.","volume":"168","author":"Bagasra","year":"1993","journal-title":"J Infect Dis"},{"key":"R7-18-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1092852900023439","article-title":"The effects of stressful life events, coping, and cortisol on HIV infection.","volume":"8","author":"Leserman","year":"2003","journal-title":"CNS Spectr"},{"key":"R8-18-20210213","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/322679","article-title":"Management of psychiatric disorders in patients infected with human immunodeficiency virus.","volume":"33","author":"Angelino","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-18-20210213","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.qai.0000147524.19122.fd","article-title":"Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients.","volume":"38","author":"Yun","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-18-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/135965350501000103","article-title":"Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.","volume":"10","author":"Bouhnik","year":"2005","journal-title":"Antivir Ther"},{"key":"R11-18-20210213","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.olq.0000223249.04456.76","article-title":"Sexually transmitted infections and HIV in the southern United States: an overview.","volume":"33","author":"Aral","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R12-18-20210213","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.qai.0000177512.30576.9c","article-title":"Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.","volume":"40","author":"Pence","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-18-20210213","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","article-title":"Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.","volume":"58","author":"Bing","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R14-18-20210213","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.158.5.725","article-title":"Meta-analysis of the relationship between HIV infection and risk for depressive disorders.","volume":"158","author":"Ciesla","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R15-18-20210213","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(03)00093-7","article-title":"Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.","volume":"114","author":"Tucker","year":"2003","journal-title":"Am J Med"},{"key":"R16-18-20210213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1525-1497.2001.016009625.x","article-title":"Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.","volume":"16","author":"Turner","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R17-18-20210213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1525-1497.1999.08198.x","article-title":"Delays in protease inhibitor use in clinical practice.","volume":"14","author":"Fairfield","year":"1999","journal-title":"J Gen Intern Med"},{"key":"R18-18-20210213","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R19-18-20210213","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4088\/PCC.v03n0609","article-title":"The comorbidity of major depression and anxiety disorders: recognition and management in primary care.","volume":"3","author":"Hirschfeld","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R20-18-20210213","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.1996.01830100035005","article-title":"Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers.","volume":"53","author":"Sherbourne","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R21-18-20210213","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"R22-18-20210213","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200666060-00004","article-title":"Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.","volume":"66","author":"Chander","year":"2006","journal-title":"Drugs"},{"key":"R23-18-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00005053-200301000-00003","article-title":"Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse.","volume":"191","author":"Dausey","year":"2003","journal-title":"J Nerv Ment Dis"},{"key":"R24-18-20210213","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.","volume":"38","author":"Parienti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R25-18-20210213","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10597-005-5076-9","article-title":"Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment.","volume":"41","author":"Winiarski","year":"2005","journal-title":"Community Ment Health J"},{"key":"R26-18-20210213","article-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Research Version, Patient Edition (SCID-I\/P).","author":"First","year":"1990"},{"key":"R27-18-20210213","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2105\/AJPH.72.9.1017","article-title":"Telephone versus in-person surveys of community health status.","volume":"72","author":"Aneshensel","year":"1982","journal-title":"Am J Public Health"},{"key":"R28-18-20210213","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/268703","article-title":"Measuring depression in the community: a comparison of telephone and personal interviews.","volume":"46","author":"Aneshensel","year":"1982","journal-title":"Public Opin Q"},{"key":"R29-18-20210213","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-3956(93)90035-Z","article-title":"Telephone assessment of depression severity.","volume":"27","author":"Simon","year":"1993","journal-title":"J Psychiatr Res"},{"key":"R30-18-20210213","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-3956(88)90006-4","article-title":"Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH diagnostic interview schedule.","volume":"22","author":"Wells","year":"1988","journal-title":"J Psychiatr Res"},{"key":"R31-18-20210213","article-title":"Applied Logistic Regression. 2nd ed.","author":"Hosmer","year":"2000"},{"key":"R32-18-20210213","first-page":"S9","article-title":"Understanding comorbidity with depression and anxiety disorders.","volume":"106","author":"Aina","year":"2006","journal-title":"J Am Osteopath Assoc"},{"key":"R33-18-20210213","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.4088\/JCP.v67n0803","article-title":"Overlap of anxiety and depression in a managed care population: prevalence and association with resource utilization.","volume":"67","author":"McLaughlin","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R34-18-20210213","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/archinte.160.21.3278","article-title":"Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.","volume":"160","author":"Ciechanowski","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"R35-18-20210213","first-page":"48","article-title":"Coexisting depression and anxiety: special diagnostic and treatment issues.","volume":"52","author":"Lydiard","year":"1991","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 8","key":"R36-18-20210213","first-page":"22","article-title":"Comorbid anxiety and depression.","volume":"66","author":"Pollack","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R37-18-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.psc.2006.12.009","article-title":"Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.","volume":"30","author":"Ostacher","year":"2007","journal-title":"Psychiatr Clin North Am"},{"key":"R38-18-20210213","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.qai.0000136739.01219.6d","article-title":"Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?","volume":"37","author":"Himelhoch","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R39-18-20210213","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/JCP.0b013e31802f0dd1","article-title":"Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.","volume":"27","author":"Dalessandro","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 1","key":"R40-18-20210213","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02791072.2003.10400510","article-title":"Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people.","volume":"35","author":"Galvan","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"R41-18-20210213","first-page":"320","article-title":"Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study.","volume":"38","author":"Li","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-18-20210213","article-title":"HIV\/AIDS Surveillance Report. Vol 17 (2005).","year":"2006"},{"key":"R43-18-20210213","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2105\/AJPH.2005.063149","article-title":"HIV infection and AIDS in the Deep South.","volume":"96","author":"Reif","year":"2006","journal-title":"Am J Public Health"},{"key":"R44-18-20210213","article-title":"The Behavioral Health Care Needs of Rural Women. The Report of the Rural Women\u2019s Work Group of the Rural Task Force of the American Psychological Association and the American Psychological Association\u2019s Committee on Rural Health 2001.","year":"2006"},{"key":"R45-18-20210213","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2105\/AJPH.91.7.1060","article-title":"HIV in the United States at the turn of the century: an epidemic in transition.","volume":"91","author":"Karon","year":"2001","journal-title":"Am J Public Health"},{"key":"R46-18-20210213","article-title":"No Time to Lose: The AIDS Crisis Is Not Over: Getting More from HIV Prevention.","year":"2001"},{"key":"R47-18-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/0278-6133.12.3.215","article-title":"Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection.","volume":"12","author":"Kelly","year":"1993","journal-title":"Health Psychol"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006842-200805000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:54:58Z","timestamp":1786035298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006842-200805000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0b013e31816aa0cc","relation":{},"ISSN":["0033-3174"],"issn-type":[{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}